event,time
50 years old ,0
    male ,0
    presented with chest pain ,0
    presented with shortness of breath ,0
    chest computed tomography showed pulmonary emboli ,-144
    hospital day 6 ,-144
    transferred to intensive care unit ,-144
    intubated for severe respiratory distress ,-144
    hospital day 7 ,-168
    repeat CT showed progressive necrosis ,-168
    underwent thoracotomy with partial decortication ,-168
    underwent right thoracoscopy ,-168
    3 chest tubes placed ,-168
    started on empiric piperacillin-tazobactam ,-168
    started on intravenous vancomycin ,-168
    hospital day 9 ,-216
    bronchoalveolar lavage ,-216
    hospital day 12 ,-288
    meropenem-susceptible A. baumannii positive ,-288
    antibiotics switched to extended infusion meropenem ,-288
    underwent another thoracotomy ,-288
    underwent RLL resection ,-288
    underwent complete decortication ,-288
    pathology demonstrated acute fibrinopurulent exudate ,-288
    resected RLL demonstrated extensive abscess ,-288
    resected RLL demonstrated necrosis ,-288
    resected RLL demonstrated hemorrhage ,-288
    hospital day 18 ,-432
    pleural tissue culture demonstrated XDR A. baumannii ,-432
    intermediate susceptibility to colistin ,-432
    tigecycline MIC 2 mg/L ,-432
    switched from meropenem to tigecycline ,-456
    hospital day 19 ,-456
    hospital day 26 ,-624
    required vasoactive agents ,-624
    CT chest demonstrated RLL pyopneumothorax ,-624
    switched tigecycline to colistin ,-624
    switched to meropenem ,-624
    hospital day 28 ,-672
    underwent bronchoscopy ,-672
    identified right bronchopleural fistula ,-672
    acute tubular necrosis ,-672
    serum creatinine increased 7-fold ,-672
    hospital day 23 ,-552
    chest tube fluid culture ,-552
    hospital day 29 ,-696
    cefiderocol susceptible ,-696
    eravacycline susceptible ,-696
    switched colistin and meropenem to cefiderocol ,-696
    hospital day 40 ,-960
    bronchial washings culture ,-960
    hospital day 45 ,-1080
    XDR A. baumannii positive ,-1080
    cefiderocol-resistant ,-1080
    hospital day 49 ,-1176
    switched cefiderocol to eravacycline ,-1176
    hospital day 54 ,-1296
    febrile ,-1296
    tachycardic ,-1296
    increased chest tube output ,-1296
    eravacycline MIC increased to 1 mg/L ,-1296
    discontinued eravacycline ,-1296
    initiated combination therapy with cefiderocol ,-1296
    initiated combination therapy with tigecycline ,-1296
    hospital day 62 ,-1488
    started sulbactam-durlobactam ,-1488
    started meropenem ,-1488
    hospital day 75 ,-1800
    chest tube output resolved ,-1800
    completed 3 weeks of antibiotic therapy ,-1800
    antibiotics discontinued ,-1800
    cleared for discharge ,-1824
    followed up with infectious diseases ,0
    at prehospital baseline ,672
